|
METTL6 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.25510002391138E-09 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.44500000246006E-08 |
| Normal-vs-Stage2 |
5.92189999999437E-05 |
| Normal-vs-Stage3 |
7.8809958559134E-11 |
| Normal-vs-Stage4 |
1.215030E-03 |
| Stage1-vs-Stage2 |
8.199400E-01 |
| Stage1-vs-Stage3 |
2.575600E-03 |
| Stage1-vs-Stage4 |
7.054400E-01 |
| Stage2-vs-Stage3 |
5.815900E-02 |
| Stage2-vs-Stage4 |
6.407600E-01 |
| Stage3-vs-Stage4 |
3.712300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.84499995678789E-10 |
| Normal-vs-AfricanAmerican |
5.389800E-04 |
| Normal-vs-Asian |
5.745800E-01 |
| Caucasian-vs-AfricanAmerican |
4.573200E-01 |
| Caucasian-vs-Asian |
1.078950E-01 |
| AfricanAmerican-vs-Asian |
2.831000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.40310005228395E-09 |
| Normal-vs-Female |
1.89460000021846E-07 |
| Male-vs-Female |
2.518600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.782500E-03 |
| Normal-vs-Age(41-60Yrs) |
6.34770000007556E-07 |
| Normal-vs-Age(61-80Yrs) |
1.10120002005942E-09 |
| Normal-vs-Age(81-100Yrs) |
2.99889999999525E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.640200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.391000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.088650E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.154200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.516500E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.237030E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
9.206200E-01 |
| Normal-vs-Grade 2 |
6.91539999708723E-08 |
| Normal-vs-Grade 3 |
4.42779146681005E-12 |
| Normal-vs-Grade 4 |
4.841100E-04 |
| Grade 1-vs-Grade 2 |
1.102160E-02 |
| Grade 1-vs-Grade 3 |
4.642100E-04 |
| Grade 1-vs-Grade 4 |
8.385800E-02 |
| Grade 2-vs-Grade 3 |
2.689900E-02 |
| Grade 2-vs-Grade 4 |
9.591800E-01 |
| Grade 3-vs-Grade 4 |
2.225000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.82349998936837E-09 |
| Normal-vs-ccB subtype |
2.40509999999139E-05 |
| ccA subtype-vs-ccB subtype |
2.392000E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.15310000004376E-07 |
| Normal-vs-N1 |
9.063300E-03 |
| N0-vs-N1 |
8.332600E-01 |
|
|
